The Ability of Different Ketohexoses to Alter Apo-A-I Structure and Function In Vitro and to Induce Hepatosteatosis, Oxidative Stress, and Impaired Plasma Lipid Profile in Hyperlipidemic Zebrafish

Abstract EN

In the current study, we have tested the nonenzymatic glycation activities of ketohexoses, such as tagatose and psicose.

Although tagatose-treated apoA-I (t-A-I) and psicose-treated apoA-I (p-A-I) exerted more inhibitory activity you cupric ion-mediated low-density lipoprotein (LDL) oxidation and oxidized LDL (oxLDL) phagocytosis into macrophage than fructose-treated apoA-I (f-A-I).

In the lipid-free state, t-A-I and f-A-I showed more multimerized band without crosslinking.

Since t-A-I lost its phospholipid binding ability, the rHDL formation was not as successful as f-A-I.

However, injecting t-A-I showed more antioxidant activities in zebrafish embryo under the presence of oxLDL.

Three weeks of consumption of fructose (50% of wt in Tetrabit/4% cholesterol) showed a 14% elevation of serum triacylglycerol (TG), while tagatose-administered group showed 30% reduction in serum TG compared to high cholesterol control.

Fructose-fed group showed the biggest area of Oil Red O staining with the intensity as strong as the HCD control.

However, tagatose-consumed group showed much lesser Oil Red O-stained area with the reduction of lipid accumulation.

In conclusion, although tagatose treatment caused modification of apoA-I, the functional loss was not as much severe as the fructose treatment in macrophage cell model, zebrafish embryo, and hypercholesterolemic zebrafish model.